YENERJO Trademark
Trademark Overview
On Friday, September 8, 2023, a trademark application was filed for YENERJO with the United States Patent and Trademark Office. The USPTO has given the YENERJO trademark a serial number of 98171607. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, May 5, 2025. This trademark is owned by Eli Lilly and Company. The YENERJO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative co...
General Information
Serial Number | 98171607 |
Word Mark | YENERJO |
Filing Date | Friday, September 8, 2023 |
Status | 731 - SECOND EXTENSION - GRANTED |
Status Date | Monday, May 5, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, April 30, 2024 |
Trademark Statements
Goods and Services | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Sunday, October 1, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Eli Lilly and Company |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Indianapolis, IN 46285 |
Party Name | Eli Lilly and Company |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Indianapolis, IN 46285 |
Trademark Events
Event Date | Event Description |
Tuesday, September 12, 2023 | NEW APPLICATION ENTERED |
Sunday, October 1, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, April 30, 2024 | PUBLISHED FOR OPPOSITION |
Sunday, March 24, 2024 | ASSIGNED TO EXAMINER |
Monday, March 25, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, April 10, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, April 30, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, June 25, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Thursday, October 17, 2024 | SOU TEAS EXTENSION RECEIVED |
Thursday, October 17, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, October 17, 2024 | SOU EXTENSION 1 FILED |
Thursday, October 17, 2024 | SOU EXTENSION 1 GRANTED |
Monday, May 5, 2025 | SOU TEAS EXTENSION RECEIVED |
Monday, May 5, 2025 | SOU EXTENSION 2 FILED |
Tuesday, May 6, 2025 | SOU EXTENSION 2 GRANTED |
Tuesday, May 6, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |